STRUCTURE OF THE GLOBAL OFFERING

In the event of a reduction in the number of Offer Shares, the Lead Global Coordinator
may, at its discretion, reallocate the number of Offer Shares to be offered in the Hong Kong
Public Offering and the International Placing, provided that
the number of Offer Shares
comprised in the Hong Kong Public Offering shall not be less than 10% of the total number
of Offer Shares available under the Global Offering (assuming the Over-allotment Option is not
exercised).

Announcement of Offer Price and Basis of Allocations

The final Offer Price, the level of indications of interest in the Global Offering, the results
of allocations and the basis of allotment of the Hong Kong Offer Shares are expected to
be announced on the South China Morning Post (in English) and the Hong Kong Economic
Times (in Chinese) and on the website of the Stock Exchange at www.hkexnews.hk and on the
website of our Company at www.junshipharma.com.

UNDERWRITING

The Hong Kong Public Offering is fully underwritten by the Hong Kong Underwriters
under the terms of the Hong Kong Underwriting Agreement and is subject to our Company and
the Lead Global Coordinator, for itself and on behalf of the Underwriters, agreeing on the Offer
Price.

We expect

to enter into the International Underwriting Agreement relating to the

International Placing on or around the Price Determination Date.

These underwriting arrangements, and the Hong Kong Underwriting Agreement and the
International Underwriting Agreement, are summarized in the section headed “Underwriting”
in this prospectus.

CONDITIONS OF THE GLOBAL OFFERING

Acceptance of all applications for the Offer Shares pursuant to the Global Offering will

be conditional on:

(a)

(b)

(c)

the Listing Committee granting approval for the listing of, and permission to deal in,
the H Shares to be issued pursuant to the Global Offering (including the additional
H Shares which may be available pursuant to the exercise of the Over-allotment
Option), and such listing and permission not subsequently having been revoked prior
to the commencement of dealings in the H Shares on the Stock Exchange;

the Offer Price having been duly agreed between us and the Lead Global
Coordinator (for itself and on behalf of the Underwriters);

the execution and delivery of the International Underwriting Agreement on or about
the Price Determination Date; and

– 362 –

